Brandywine Global Investment Management, LLC Lannett CO Inc Transaction History

Brandywine Global Investment Management, LLC

$14.2 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$4.75 - $14.5 $190,408 - $581,247	-40,086 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$13.3 - $17.45 $13,459 - $17,659	-1,012 Reduced 2.46%	40,086 $546,000
Q1 2018 May 15, 2018	SELL	$14.7 - $24.95 $103,782 - $176,147	-7,060 Reduced 14.66%	41,098 $660,000
Q4 2017 Feb 14, 2018	SELL	$19.9 - $29.25 $105,350 - $154,849	-5,294 Reduced 9.9%	48,158 $1.12 Million
Q3 2017 Nov 14, 2017	SELL	$15.1 - $19.25 $29,248 - $37,287	-1,937 Reduced 3.5%	53,452 $987,000
Q2 2017 Aug 14, 2017	BUY	N/A	55,389	55,389 $1.13 Million

Others Institutions Holding LCI

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About LANNETT CO INC

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

More about LCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.

Account